(NP (NP (NP-COOD (NP (NN FK506)) (CC and) (NP (NN ciclosporin))) (: :) (NP (NP (JJ molecular) (NNS probes)) (PP (IN for) (S (NP-SBJ (-NONE- *)) (VP (VBG studying) (NP (JJ intracellular) (NN signal) (NN transduction))))))) (. .))
(S (NP-SBJ-33 (DT The) (NNS immunosuppressants) (NP-COOD (NP (NN ciclosporin)) (CC and) (NP (NN FK506)))) (VP (VBP block) (NP (NP (DT the) (JJ Ca-LRB-2+-RRB--dependent) (NN signal-transduction) (NN pathway)) (VP (VBG emanating) (PP (IN from) (NP (DT the) (NN T-cell) (NN receptor))))) (, ,) (S (NP-SBJ (-NONE- *-33)) (ADVP (RB thereby)) (VP (VBG inhibiting) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN helper) (NN T) (NNS cells))))))) (. .))
(S (S (NP-SBJ (-NONE- *-34)) (VP (VBG Using) (NP (DT these) (NNS drugs)) (PP (IN as) (NP (NNS probes))))) (, ,) (NP-SBJ-COOD-34 (NP (NNS chemists)) (CC and) (NP (NNS biologists))) (VP (VBP have) (VP (VBN uncovered) (NP (NP (JJ several) (JJ intracellular) (NN signalling) (NNS molecules)) (VP (VBG bridging) (NP-COOD (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (NN second-messenger) (NN Ca2+) (NNS ions)))) (CC and) (NP (NP (DT the) (JJ transcriptional) (NN activation)) (PP (IN of) (NP (NN IL-2)))))) (, ,) (SBAR (WHPP-35 (IN among) (WHNP (WDT which))) (SINV (VP (VBP are) (PP-PRD (-NONE- *T*-35))) (NP-SBJ-COOD (NP (NN calmodulin)) (, ,) (NP (NN calcineurin)) (CC and) (NP (NP (NP (DT the) (JJ nuclear) (NN factor)) (PP (IN of) (NP (VBN activated) (NN T) (NNS cells)))) (PRN (-LRB- -LRB-) (NP (NN NF-AT)) (-RRB- -RRB-))))))))) (. .))
(S (S (ADVP (RB Hence)) (, ,) (NP-SBJ (NN Ca2+)) (VP (VBZ binds) (PP (TO to) (NP (NN calmodulin))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG leading) (PP (TO to) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NN calmodulin))) (PP (TO to) (NP (NN calcineurin))))))))) (: ;) (S (NP-SBJ (DT the) (VBN activated) (NN calcineurin)) (, ,) (PP (IN in) (NP (NN turn))) (, ,) (VP (MD may) (VP (VB dephosphorylate) (NP (NP (DT the) (JJ cytoplasmic) (NN subunit)) (PP (IN of) (NP (NN NF-AT)))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG resulting) (PP (IN in) (NP (NP (PRP$ its) (NN translocation)) (PP (IN from) (NP (DT the) (NN cytoplasm))) (PP (IN into) (NP (DT the) (NN nucleus))) (SBAR (WHADVP-100 (-NONE- 0)) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB form) (NP (DT a) (JJ competent) (JJ transcriptional) (NN activator)) (ADVP (-NONE- *T*-100))))))))))))) (. .))
(S (SBAR (IN As) (S (NP-SBJ-37 (-NONE- *)) (VP (VBN described) (NP (-NONE- *-37)) (PP (IN by) (NP-LGS (NNP Jun) (NNP Liu)))))) (, ,) (NP-SBJ (DT these) (NNS drugs)) (VP (VBP manifest) (NP (PRP$ their) (NNS effects)) (PP (IN in) (NP (DT an) (JJ unprecedented) (NN fashion)))) (. .))
(S (NP-SBJ (PRP They)) (VP (VBP do) (RB not) (ADVP (RB directly)) (VP (VB intercept) (NP (JJ intracellular) (NN signalling) (NNS molecules)))) (. .))
(S (ADVP (RB Instead)) (, ,) (NP-SBJ-38 (PRP they)) (VP-COOD (VP (VBP form) (NP (JJ tight) (NNS complexes)) (PP (IN with) (NP (NP (CD two) (JJ different) (NNS classes)) (PP (IN of) (NP (NP (JJ abundant) (JJ cytosolic) (NNS receptors)) (VP (VBN called) (S (NP-SBJ (-NONE- *)) (NP-PRD (NNS immunophilins)))))))) (PP-TMP (IN upon) (S (NP-SBJ (-NONE- *-38)) (VP (VBG entering) (NP (DT the) (NN cell)))))) (, ,) (CC and) (VP (ADVP (RB consequently)) (VBP inhibit) (NP (PRP$ their) (JJ peptidyl) (JJ prolyl) (JJ cis-trans) (NN isomerase) (NNS activities)))) (. .))
(S (NP-SBJ (DT The) (CD two) (ADJP (RB structurally) (JJ distinct)) (JJ immunophilin-drug) (NNS complexes)) (VP (VP-COOD (VP (VBP bind) (PP (TO to) (NP (-NONE- *RNR*-39)))) (, ,) (CC and) (VP (VBP inhibit) (NP (-NONE- *RNR*-39))) (, ,)) (NP-39 (NP (DT the) (JJ phosphatase) (NN activity)) (PP (IN of) (NP (NN calcineurin))))) (. .))
